HSTS

Amazon

IPv6

Facebook Sharer

reCAPTCHA v2

GoDaddy SSL

Invalid Certificate Dates

Matomo

Chief Financial Officer

Brad Dahms

Chief Medical Officer

David Kerstein

President and CEO

Tim Clackson

Co-Founder, Chief Scientific Officer

Victor Rivera

Founder, President Research & Development

William Shakespeare

Senior Vice President People & Culture

Alicja Januszewicz

Vice President Legal Affairs

Ben Enerson

Vice President, Controller

Kristine Callahan

Senior Vice President, Technical Operations

Leonard Rozamus

Senior Vice President, DMPK & Preclinical Safety

Narayana Narasimhan

Carl L. Gordon

Michael Rome

Kathy Yi

Iain Dukes

President & CEO

William C. Shakespeare

Timothy P. Clackson

United States Acquired Companies With Fewer Than 100 Employees (Top 10K)

East Coast Acquired Companies With Fewer Than 1000 Employees (Top 10K)

Health Care Companies With Less Than $500M in Revenue (Top 10K)

East Coast Companies With Less Than $50M in Revenue (Top 10K)

Theseus Pharmaceuticals is a technology-based company.

Foresite Capital

Series B - Theseus Pharmaceuticals

OrbiMed

Series A - Theseus Pharmaceuticals

New York

United States

North America

Theseus Pharmaceuticals

Theseus Investor Seeks Appraisal After Concentra Merger

Theseus Pharmaceuticals Announces Closing of Tender Offer

Theseus Pharmaceuticals, Inc.(NasdaqGS:THRX) dropped from S&P TMI Index

Theseus: Biotech Buyout Remains Attractive At $4.06 Because Of 2-Part CVR

THESEUS PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn ...

Concentra Biosciences’ $185 Million Acquisition of Theseus Pharmaceuticals

Thinking about buying stock in Porch Group, Hookipa Pharma, Wheels Up Experience, Theseus Pharmaceuticals, or Allovir?

Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value Right

Theseus Pharmaceuticals Fires CEO Clackson, Medical Chief Kerstein

Pfizer is a global pharmaceutical company that develops, manufactures, and sells prescription medicines as well as vaccines and consumer healthcare products.

Pfizer Inc.

Merck is a leading global biopharmaceutical company that has been inventing for life for more than a century, bringing forward medicines and vaccines for many of the world's most challenging diseases.

Merck & Co., Inc.

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases.

Bristol Myers Squibb

Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients.

Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also develops fourth-generation EGFR inhibitor that is active against C797S, an EGFR mutation that causes resistance to first- or later-line osimertinib treatment in patients with non-small cell lung cancer. Its development programs address drug resistance mutations in key driver oncogenes, which are mutated genes that cause cancer. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.

Theseus Pharmaceuticals, Inc.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Mar 5, 2024 11:06 AM	987b8651
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 5, 2024 11:06 AM	7bc7cf1a
company summary	general
signals	general
crunchbase trigger	general	Nov 22, 2024 7:44 AM	377e6096
crunchbase profile	general	Nov 22, 2024 9:30 AM	6b5cbc12
li profile	general
translate crunchbase fundingrounds	general	Nov 22, 2024 2:02 PM	48954d27
peers	general
news basic	general	Mar 5, 2024 11:06 AM	9cee77e7
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:THESEUSRX

Theseus Pharmaceuticals, Inc.

Last Close

4.06

13/02 20:59

Market Cap

181.50M

Beta: -

Volume Today

677.69K

Avg: -